Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Weekly
Analytics
American chemical industry news
(page 6)
7 January 2026
Lilly Acquires Ventyx Biosciences to Enhance Inflammatory Disease Therapies
Ventyx's small molecule pipeline targets chronic inflammation in cardiometabolic, neurodegenerative, and inflammatory diseases, aiming for improved efficacy and safety.
7 January 2026
Topsoe Announces CEO Transition: Scaltritti to Succeed Baan
Baan steps down as CEO in 2026. Scaltritti, current CCO, will succeed him. Baan led significant transformations, including green hydrogen and sustainable fuel initiatives.
7 January 2026
Corteva and bp Form Etlas Biofuel Feedstock Venture
Etlas will produce biofuel feedstocks from crops, aiming for 1M tonnes annually by mid-2030s, supporting SAF and RD demand growth without extra land use.
7 January 2026
Merck Finalizes Cidara Therapeutics Acquisition
Merck acquires Cidara, enhancing its respiratory portfolio with CD388, a long-acting antiviral for influenza prevention, impacting 2026 R&D expenses and EPS.
7 January 2026
Sunrise Wind Challenges Lease Suspension in Court
Sunrise Wind seeks a preliminary injunction against a lease suspension, citing legal violations and project delays, impacting energy supply and jobs.
6 January 2026
LibertyStream Produces Spec-Compliant Lithium Carbonate in Texas
Consistent lithium carbonate production validated; customer sampling underway. Plans for bulk sampling and offtake discussions aim for commercial volumes by 2027.
How does the American chemical industry perform?
Find out with
chemXplore Analytics
Learn more
6 January 2026
Johnson & Johnson Reports Positive Phase 2 Results for Nipocalimab in SLE Study
Nipocalimab shows promise in reducing SLE activity, meeting primary and secondary endpoints in Phase 2b JASMINE study, with a consistent safety profile. Phase 3 program initiated.
6 January 2026
Johnson & Johnson Seeks EMA Approval for TECVAYLI and DARZALEX Combo in Relapsed Multiple Myeloma
The EMA application is based on Phase 3 data showing improved survival in relapsed multiple myeloma with TECVAYLI and DARZALEX, with similar adverse event rates to standard care.
5 January 2026
TechnipFMC Secures iEPCI™ Contract for bp's Tiber Project
TechnipFMC awarded iEPCI™ contract for bp's Tiber project, leveraging Kaskida's 20K psi technology for efficient, collaborative greenfield development in the Gulf of America.
5 January 2026
Takeda and Protagonist Submit NDA for Rusfertide in Polycythemia Vera Treatment
Rusfertide shows promise in controlling hematocrit and reducing phlebotomy in PV patients, meeting key endpoints in Phase 3 VERIFY study.
2 January 2026
Technip Energies Acquires Ecovyst's Advanced Materials & Catalysts Business
The acquisition enhances Technip Energies' catalyst capabilities, supports growth in sustainable fuels, and adds 330 employees, boosting earnings and value creation.
2 January 2026
Brightmark RNG Holdings Delivers First Gas at 10 Midwest Projects
Brightmark's RNG projects reduce emissions, support local economies, and highlight renewable natural gas potential through anaerobic digestion with farmers.
29 December 2025
Huntsman Names Amy Smedley as EVP and General Counsel
Amy Smedley rejoins Huntsman as EVP, General Counsel & Secretary, succeeding David Stryker. She brings extensive legal experience from Savage Companies and her previous tenure at Huntsman.
29 December 2025
OCI Global's Beaumont Facility Begins Ammonia Production
The Beaumont facility in Texas has started ammonia production after systems testing, with handover to Woodside Energy expected in early 2026.
22 December 2025
Technip Energies Secures Equipment Orders from Commonwealth LNG
Technip Energies advances Commonwealth LNG project with key equipment orders, supporting modular construction and accelerating progress towards a 2026 investment decision.
22 December 2025
FDA Approves Novo Nordisk's Oral Wegovy for Adult Weight Loss
FDA approves Wegovy pill, the first oral GLP-1 for weight loss, showing ~17% loss in trials. Available January at $149/month, it also reduces cardiovascular risks in adults with obesity.
22 December 2025
Novo Nordisk: FDA Approves Wegovy® Oral Pill for Weight Management
Wegovy® pill, an oral GLP-1, shows 16.6% weight loss in trials. Launch expected in the US by January 2026. Approval based on OASIS and SELECT trials.
22 December 2025
Perpetual Next Completes €35M Bond Redemption Early
The company redeems bonds as part of a debt reduction plan, preparing for 2026 growth capital. It is also expanding biomethanol production across Europe and the U.S.
22 December 2025
INEOS Energy Announces Gulf of America Oil Discovery
The Nashville well confirms high-quality oil in the Gulf's deepwater. Further analysis will assess the find's size, potentially enhancing energy security and supply.
22 December 2025
Roche's Lunsumio VELO Approved by FDA for Subcutaneous Use in Follicular Lymphoma
Lunsumio VELO cuts treatment time to one minute for relapsed follicular lymphoma, offering outpatient care with a manageable safety profile.
19 December 2025
Genentech and U.S. Government Reach Drug Cost Agreement
Agreement lowers Medicaid drug costs, promotes innovation rewards, expands patient access, and exempts tariffs, supporting U.S. manufacturing and job growth.
19 December 2025
Merck and U.S. Government Partner to Expand Medicine Access and Reduce Costs
Merck commits $70B to U.S. production, offers key drugs at reduced prices, and delays tariffs to enhance domestic manufacturing and innovation.
18 December 2025
INEOS' Jim Ratcliffe Urges EU Action to Save Chemical Industry
Ratcliffe warns of Europe's chemical industry decline due to Chinese imports and high energy costs, urging immediate tariff protection and carbon tax action to prevent further facility closures.
18 December 2025
FDA Approves Boehringer Ingelheim's JASCAYD for Progressive Pulmonary Fibrosis
JASCAYD, a PDE4B inhibitor, slows lung function decline in progressive pulmonary fibrosis, offering a new treatment option based on Phase III trial results.
18 December 2025
Johnson & Johnson's TRUFILL n-BCA Approved by FDA for Chronic Subdural Hematoma Treatment
FDA approves TRUFILL n-BCA for MMA embolization in chronic subdural hematoma, offering a minimally invasive alternative to surgery with proven safety and effectiveness.
18 December 2025
Lilly's Orforglipron Maintains Weight Loss in Phase 3 Trial
Orforglipron met primary and key secondary endpoints for weight maintenance at 52 weeks post-weight loss on Wegovy. FDA submission for obesity treatment is underway.
18 December 2025
Valerie Mars Joins PureCycle Board
Valerie Mars, former Mars Inc. executive, joins PureCycle's board in 2026, bringing expertise in sustainability and business scaling.
18 December 2025
Novo Nordisk Seeks FDA Approval for CagriSema, a Weekly Obesity Treatment
CagriSema, combining cagrilintide and semaglutide, shows 23% weight loss in trials. If approved, it offers a new obesity treatment option.
18 December 2025
Novo Nordisk Seeks FDA Approval for CagriSema, a Weekly Obesity Treatment
CagriSema, a weekly injectable combining GLP-1 and amylin analogues, shows promising weight loss results in trials and awaits FDA review for obesity management.
18 December 2025
AkzoNobel Invests €50M in US Aerospace Coatings Expansion
€50M investment upgrades Waukegan site, boosts capacity, automation, and warehousing, enhancing aerospace coatings production and customer responsiveness.
← Previous
Next →
